News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.

Test could predict whether breast cancer will spread to the brain
Women with particularly aggressive forms of breast cancer could be identified by a test that predicts whether the disease is likely to spread to the brain.
Another successful year for the ICR team at the Royal Parks Half Marathon
All 24 of our runners in the Royal Parks Half Marathon completed the 13.1 mile course and together are set to raise £25,000 for our research.

ICR scientists set to conquer Mount Snowdon for research into rare teenage cancer
A team of scientists from The Institute of Cancer Research, London, are embarking on a series of fundraising challenges in support of two parent-led charities committed to funding the ICR’s research into teenage cancer.

New test to predict relapse of testicular cancer
Assessing just three features of a common kind of testicular cancer can identify those at most at risk of relapse.
.jpg?sfvrsn=5ee5f73f_2)
Blood test could match cancer patients to best treatments
Scientists have developed a blood test that could match cancer patients with the most suitable therapy and track the tumour’s progress to see if the treatment is working.

New test could help personalise treatment for common childhood cancer
A new test that examines the activity of only five genes can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma.

Abiraterone made available earlier for men in Scotland
Abiraterone has been made available on the NHS in Scotland for men with advanced prostate cancer before treatment with chemotherapy.

Scientists uncover four different types of bowel cancer
Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.
Gene may explain elephants’ surprisingly low cancer rate
Scientists believe they may be able to explain elephants’ low cancer rates – providing intriguing clues for preventing cancer in humans.
New Head of Cancer Therapeutics sets sights on cancers of unmet need
Dr Rajesh Chopra, a global leader in the development of molecularly targeted cancer drugs, will spearhead the ICR's world-leading work in cancer therapeutics.

Major study finds five new genetic variants linked to brain cancer
The biggest ever study of DNA from the most common form of brain cancer has discovered five new genetic variants associated with the disease.

HRT safe and perhaps beneficial in women treated for ovarian cancer, major trial shows
Women with the commonest type of ovarian cancer can safely take hormone replacement therapy according to results from a 24-year, phase III international trial.
